Poland· PL-100062430

Spasmalgon

A pitofenon mit analgetika product containing metamizolum natricum + pitofenoni hydrochloridum + fenpiverini bromidum, registered in Poland by Sopharma Warszawa Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC A03DA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSpasmalgonATCA03DA02REGISTER NO.PL-100062430PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Pitofenon mit analgetika is registered in 3 of 19 countries.

Countries holding a registration under ATC A03DA02 (pitofenon mit analgetika), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Pitofenon mit analgetika · ATC A03DA02

3 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Metamizolum natricum + Pitofenoni hydrochloridum + Fenpiverini bromidum
Manufacturer
Sopharma Warszawa Sp. z o.o.
Country
Poland (PL)
ATC code
A03DA02
ATC class
Pitofenon mit Analgetika
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990345816

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pitofenon mit analgetika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pitofenon mit analgetika products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Bulgaria · Спазмалгон, Спазмоблок
  • Czechia · Analgin
  • Latvia · Spasmalgon
  • Romania · Piafen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be0cb2f2-9ce9-44d2-ba16-e98fc92635c5
GET /v1/drugs/be0cb2f2-9ce9-44d2-ba16-e98fc92635c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "(500 mg + 2 mg + 0,02 mg)/ml",
  "packaging": "05909990345816 ¦ Rp ¦ 9227\n10 amp. 5 ml",
  "substance": "Metamizolum natricum 500 mg/ml + Pitofenoni hydrochloridum 2 mg/ml + Fenpiverini bromidum 0.02 mg/ml",
  "common_name": "Metamizolum natricum + Pitofenoni hydrochloridum + Fenpiverini bromidum",
  "pl_product_id": "100062430",
  "pozwolenie_nr": "03458",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about pitofenon mit analgetika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.